Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.

Blood - 21 Jan 2010

Hussein Kebede, Pardanani Animesh D, Van Dyke Daniel L, Hanson Curtis A, Tefferi Ayalew

Abstract excerpt

Among 200 patients with primary myelofibrosis, karyotype at diagnosis was abnormal in 83 (42%). To assess their individual prognostic impact, specific cytogenetic abnormalities with more than or equal to 5 informative cases were identified and the rest grouped separately as "other abnormalities."...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Cytogenetics
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to International Cooperation

Share to Janus Kinase 2

Share to Primary Myelofibrosis

Share to Research Design

Share to Survival Analysis

Source

Identifiers

PMID: 19901264
DOI: 10.1182/blood-2009-08-240135

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19901264-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.PMID 19901264Read ↗

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patientsSemantic proximity Read ↗

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients.Semantic proximity Read ↗

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease courseSemantic proximity Read ↗

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.Semantic proximity Read ↗

Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromesSemantic proximity Read ↗

Integration of Mutations and Karyotype Towards a Genetics-Based Prognostic Scoring System (GPSS) for Primary MyelofibrosisSemantic proximity Read ↗

The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.Semantic proximity Read ↗

Prognostication in MF: from CBC to cytogenetics to molecular markers.Semantic proximity Read ↗

Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 casesSemantic proximity Read ↗

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.Semantic proximity Read ↗

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.Semantic proximity Read ↗

Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.